Physician profile
Nimmy Mathew
NPI 1124512843
$2,437.85
in general payments reported to CMS, 2019-2025
19 companies · $452 in 2025
The $452 reported for 2025 was more than what 89% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $99.40 · 2021: $107 · 2022: $825 · 2023: $453 · 2024: $501 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $472.05 | 2022-2024 | Farxiga, Andexxa |
| Janssen Pharmaceuticals, INC | $413.98 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $342.69 | 2022-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $333.85 | 2022-2025 | |
| Novo Nordisk INC | $172.53 | 2021-2025 | Rybelsus, Ozempic |
| Ferring Pharmaceuticals INC. | $157.48 | 2022-2023 | Rebyota |
| Pfizer INC. | $129.55 | 2021-2025 | |
| Celgene Corporation | $99.40 | 2020 | |
| Ceribell, INC. | $67.63 | 2024-2025 | Pocket Eeg Device |
| Gilead Sciences, INC. | $38.61 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $31.67 | 2025 | Terlivaz |
| Ucb, INC. | $30.91 | 2025 | Briviact |
| Lexicon Pharmaceuticals, INC. | $29.01 | 2023 | Inpefa |
| Kestra Medical Technology Services, INC. | $23.07 | 2025 | Assure Wcd |
| Eisai INC. | $21.77 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.18 | 2023 | Zerbaxa, Dificid |
| Janssen Scientific Affairs, LLC | $18.85 | 2023 | Xarelto |
| Smith+Nephew, INC. | $18.78 | 2025 | Collagenase Santyl |
| W. L. Gore & Associates, INC. | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nimmy Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.